Table 2.
Changes in clinical parameters before and after three months for the controls and group A
| Controls | Group A | |||
|---|---|---|---|---|
| Pre | 3M | Pre | 3M | |
| BMI (Kg/m2) | 25.0 ± 1.4 | 24.5 ± 1.3 | 25.5 ± 2.0 | 25.8 ± 2.1 |
| SBP (mmHg) | 140.3 ± 2.7 | 137.0 ± 1.5 | 144.3 ± 2.6 | 125.6 ± 4.6* |
| DBP(mmHg) | 80.6 ± 3.5 | 79.7 ± 3.3 | 85.3 ± 1.9 | 83.0 ± 1.3 |
| FPG(mg/dl) | 112 ± 4.4 | 113 ± 3.7 | 105 ± 2.6 | 103 ± 3.7 |
| FIRI (μU/ml) | 7.9 ± 1.7 | 7.8 ± 1.6 | 7.6 ± 0.9 | 8.3 ± 0.4 |
| AUC for PG (mg/dl·min) | 21412.5 ± 731 | 19767.5 ± 655* | 21432.5 ± 784 | 20080.0 ± 719 |
| AUC for IRI (μU/ml·min) | 6622.2 ± 1469 | 4501.0 ± 677 | 5175.5 ± 940 | 5395.2 ± 676 |
| HOMA-R | 2.18 ± 0.5 | 2.17 ± 0.4 | 1.97 ± 0.2 | 2.16 ± 0.1 |
| Insulinogenic | 0.48 ± 0.1 | 0.46 ± 0.1 | 0.32 ± 0.0 | 0.47 ± 0.1* |
Values are expressed as mean ± SEM.
Abbreviation: AUC = the area under the curve.
*
p < 0.05 vs. baseline data for each group.